Introduction {#S0001}
============

Tuberculosis (TB) is one of the most important infectious diseases, with an estimated 9.0 million new cases and 1.5 million deaths worldwide in 2013, and more than half were in the South-East Asia and Western Pacific Regions \[[@CIT0001]\]. It is suggested that the susceptibility to disease after infection with *Mycobacterium tuberculosis* is influenced by many risk factors, such as malnutrition, HIV infection, and environmental and host genetic factors \[[@CIT0002]--[@CIT0005]\]. Host genetic factors implicated in human susceptibility to TB include NRAMP, HLA-DQB1, interleukin (IL) genes and the vitamin D receptor (VDR) \[[@CIT0006]--[@CIT0008]\].

Vitamin D deficiency seems to be involved in susceptibility to TB and severity of the disease \[[@CIT0009]\], and 1,25-dihydroxyvitamin D~3~, the activated form of vitamin D, is a potent immune modulator. Expression and nuclear activation of the VDR are essential for these activities of vitamin D. The VDR gene is located on the long arm of chromosome 12, and several polymorphisms occur in the 5′ regulatory region, coding region and 3′ untranslated region (UTR) \[[@CIT0010]\]. Among all the gene loci, the one most studied recently is FokI \[[@CIT0011]--[@CIT0015]\], which can regulate the transcriptional activity of the gene \[[@CIT0016]\]. FokI polymorphism in combination with low serum vitamin D~3~ may attenuate VDR functions, which in turn is strongly associated with TB \[[@CIT0011]\]. Several studies have tried to investigate the role of FokI gene polymorphism on susceptibility to TB, but they have not reached a consensus. To date, two analyses on the FokI polymorphism and TB risk across different ethnicities have been reported \[[@CIT0017], [@CIT0018]\], but they failed to identify a significant association of FokI polymorphism in overall populations. In addition, more recent studies concerning the association between the polymorphism and TB risk in different populations have not included the two analyses \[[@CIT0008], [@CIT0012]--[@CIT0015], [@CIT0019]--[@CIT0024]\]. Furthermore, several important factors which may bias the results were not clearly addressed, such as Hardy-Weinberg equilibrium (HWE). Thus, it is necessary to evaluate the true association of the VDR FokI gene polymorphism and the risk of TB. In the present study, we performed an updated meta-analysis to address these discrepancies and to explore the risk factors associated with TB.

Material and methods {#S0002}
====================

Literature search strategy {#S20003}
--------------------------

We performed a literature search of the PubMed, Web of Science and Embase web databases with a combination of the key words ''VDR'' or "Vitamin D receptor"; "FokI", "rs10735810"; "polymorphism" AND "Tuberculosis'' up to January 2015. Furthermore, we evaluated potentially relevant genetic association studies by manual searching of references of relative articles and reviews. Search results were limited to human populations. No language restrictions were applied.

Inclusion and exclusion criteria {#S20004}
--------------------------------

Published articles included in the current meta-analysis were selected according to the following criteria: (1) appraisal of the association between VDR FokI gene polymorphism and TB risk, (2) case-control study design, (3) with clearly described and confirmed TB patients and TB-free controls, (4) containing available genotype frequency in cases and controls. The major reasons for study exclusion were data overlapping, case-only studies, reviews, repeated literature, and without genotype frequencies.

Data extraction and quality assessment {#S20005}
--------------------------------------

Data of each retrieved publication were independently abstracted in duplicate by two independent investigators with a standard procedure. Data extracted from the retrieved publications included the name of the first author, publication year, the country of origin, ethnicity, source of controls, number of cases and controls, study type, diagnosis method of cases, the selection of controls and genotype frequencies. The Hardy-Weinberg equilibrium (HWE) was examined by χ^2^ test (*p* \< 0.05 was considered as significant disequilibrium) based on FokI genotyping distribution in controls.

Statistical analysis {#S20006}
--------------------

Data from the meta-analysis were analyzed using STATA software (Version 12.1; Stata Corp, College Station, Texas, USA). The significance of the association for five comparison models -- allele model (f vs. F), homozygote model (ff vs. FF), heterozygote model (Ff vs. FF), dominant model (ff + Ff vs. FF) and recessive model (ff vs. Ff + FF) -- was evaluated for 34 studies separately. All associations were evaluated by calculating odds ratios (ORs) with the 95% confidence interval (CI). The statistical heterogeneity between studies was checked using the χ^2^-based Q test and considered significant at *p* \< 0.05. When there was no significant heterogeneity, the fixed effects model (Mantel-Haenszel method) was used; otherwise, the random-effects model (the DerSimonian and Laird method) was used. Sensitivity analyses were performed to identify an individual study\'s effect on pooled results and test the reliability of results. Meta-regression analysis was performed to explore the source of potential heterogeneity. Stratification analyses were performed to further identify the possible source of heterogeneity among variables, such as ethnicity and sample size (studies with more than 500 participants were defined as ''large'', and studies with less than 500 participants were defined as ''small''). Publication bias was assessed with both Egger\'s test and Begg\'s funnel plot, and the statistical significance was defined as *p* \< 0.05. All *p* values were two-sided.

Results {#S0007}
=======

Characteristics of enrolled studies {#S20008}
-----------------------------------

A flow chart of the study selection process is shown in [Figure 1](#F0001){ref-type="fig"}. According to the inclusion criteria, 34 qualified case-control studies were selected in the final analysis after the literature search from the PubMed (Medline), Web of Science and Embase web databases \[[@CIT0008], [@CIT0010]--[@CIT0015], [@CIT0019]--[@CIT0045]\]. Twenty-four studies were based on Asian populations \[[@CIT0008], [@CIT0010]--[@CIT0013], [@CIT0019]--[@CIT0037]\], seven were based on African populations \[[@CIT0014], [@CIT0015], [@CIT0038]--[@CIT0042]\] and the remaining three were conducted in Europe and America \[[@CIT0043]--[@CIT0045]\]. The eligible studies contained 4 "large" studies \[[@CIT0019], [@CIT0029], [@CIT0040], [@CIT0042]\] and 30 "small" studies \[[@CIT0008], [@CIT0010]--[@CIT0015], [@CIT0021]--[@CIT0028], [@CIT0030]--[@CIT0039]\]. Thirty studies were genotyped by restriction fragment length polymorphism (RFLP) analysis and five were conducted by other methods \[[@CIT0019], [@CIT0023], [@CIT0038], [@CIT0040], [@CIT0041]\]. The detailed characteristics of the enrolled studies are listed in [Table I](#T0001){ref-type="table"}. A total of 5669 TB cases were obtained in the 34 studies, including 5126 (92.3%) with pulmonary TB and 426 (7.7%) with extra-pulmonary TB. The corresponding controls for the TB cases numbered 6525. Distribution of genotypes and HWE *p*-values in the controls are shown in [Table II](#T0002){ref-type="table"}. Among the controls, the genotype distribution for 31 studies of the assessed polymorphisms was in HWE, except for 3 studies from India and Iran \[[@CIT0031], [@CIT0032], [@CIT0035]\].

![Flow diagram of search strategy and study selection process (TIF)](AMS-12-27637-g001){#F0001}

###### 

Main characteristics of included studies summarized for the meta-analysis

  Year   First author   Country                         Ethnicity                                                        Study design   Tuberculosis Part of the body                                Sample size Cases/controls   Diagnosis method                                       Genotyping method   Controls source                                                   HIV status                                              Age, gender          Diabetes status
  ------ -------------- ------------------------------- ---------------------------------------------------------------- -------------- ------------------------------------------------------------ ---------------------------- ------------------------------------------------------ ------------------- ----------------------------------------------------------------- ------------------------------------------------------- -------------------- -----------------
  2014   Arji           Morocco                         Arab or Berber                                                   PB             Pulmonary tuberculosis                                       274/203                      AFB smear and culture                                  PCR-RFLP            Healthy persons                                                   Negative                                                Matched              Negative
  2014   Mahmoud        Egypt                           Egyptian                                                         PB             Pulmonary tuberculosis                                       40/25                        AFB smear and culture                                  PCR-RFLP            Healthy persons                                                   Not available                                           Matched              Negative
  2014   Sinaga         Indonesian                      Indonesian Batak                                                 PB             Pulmonary tuberculosis                                       76/76                        Clinical evaluation, AFB smear and chest radiography   PCR-RFLP            Healthy health workers, tuberculin skin test positivity (61.7%)   Negative                                                Matched              Negative
  2013   Wu             China                           Chinese Kazakh                                                   PB             Pulmonary tuberculosis                                       213/211                      Clinical symptoms bacteriology X-ray                   PCR-RFLP            Healthy persons                                                   Negative                                                Matched              Negative
  2013   Joshi          India                           Indian                                                           PB             Pulmonary tuberculosis                                       110/225                      AFB smear                                              PCR-RFLP            Household contacts (110) and healthy persons (115)                Negative                                                Matched              Negative
  2012   Rathored       India                           Indian                                                           PB             MDR tuberculosis and drug-sensitive pulmonary tuberculosis   692/205                      AFB smear and culture                                  PCR-RFLP            Healthy persons                                                   Negative                                                Matched              Negative
  2011   Kim            South Korean                    Korean                                                           PB             Pulmonary (98) and extra-pulmonary tuberculosis (62)         160/156                      AFB smear and culture                                  Pyro sequencing     Healthy persons                                                   Not available                                           Matched              Not available
  2011   Kang           South Korean                    Korean                                                           PB             Pulmonary tuberculosis                                       103/105                      AFB smear and culture                                  PCR-RFLP            Healthy persons                                                   Not available                                           Matched              Not available
  2011   Singh          India                           Indo-Caucasian Brahmin caste                                     HB, PB         Pulmonary tuberculosis                                       101/225                      AFB smear or culture                                   PCR-RFLP            Healthy persons                                                   Negative                                                Not matched          Not available
  2011   Sharma         India                           Indian                                                           PB             Pulmonary tuberculosis                                       474/607                      AFB smear or culture                                   PCR-RFLP            Healthy persons                                                   Not available                                           Matched              Not available
  2011   Ates           Turkey                          Anatolian                                                        PB             Pulmonary (98) and extra-pulmonary tuberculosis (30)         128/80                       AFB smear or culture                                   PCR-RFLP            Healthy persons                                                   Not available                                           Matched              Not available
  2010   Marashian      Iran                            Iranian                                                          HB             Pulmonary tuberculosis                                       164/50                       AFB smear and X-ray                                    PCR-RFLP            Contacts                                                          Not available                                           Matched              Not available
  2010   Zhang          China                           Chinese Han                                                      PB             Spinal tuberculosis                                          110/102                      Postoperative pathology                                PCR-RFLP            Unrelated contacts                                                Negative                                                Matched              Negative
  2009   Banoei         Iran                            Iranian                                                          PB             Pulmonary tuberculosis                                       60/62                        Confirmed in Massih Daneshvari                         PCR-RFLP            Healthy subjects                                                  Negative                                                Matched              Negative
  2009   Merza          Iran                            Iranian                                                          HB             Pulmonary tuberculosis                                       117/60                       AFB smear and X-ray                                    PCR-RFLP            Contacts                                                          Not available                                           Matched              Not available
  2009   Vidyarani      India                           Dravidian                                                        PB             Pulmonary tuberculosis                                       40/49                        AFB smear and culture                                  PCR-RFLP            Normal healthy subjects                                           Not available                                           Matched              Not available
  2009   Selvaraj       India                           Indian                                                           HB             Pulmonary tuberculosis                                       65/60                        Clinical symptom, AFB smear and culture                PCR-RFLP            Healthy subjects                                                  Negative                                                Matched              Not available
  2009   Alagarasu      India                           Dravidian                                                        HB             Pulmonary (187) and extra-pulmonary tuberculosis (30)        217/144                      AFB smear, clinical criteria and X-ray                 PCR-RFLP            Healthy controls                                                  Cases (51%), controls (0)                               Matched              Not available
  2008   Selvaraj       India                           Dravidian                                                        HB             Pulmonary tuberculosis                                       51/60                        AFB smear and culture                                  PCR-RFLP            Normal healthy subjects                                           Negative                                                Matched              Not available
  2008   Liu            China                           Chinese Han                                                      PB             Pulmonary tuberculosis                                       60/30                        AFB smear and culture                                  SNaPshot            Normal healthy subjects                                           Negative                                                Matched              Negative
  2007   Wilbur         Paraguay                        Ache, Chiripa, GuaranÍ                                           PB             Pulmonary tuberculosis                                       54/124                       Clinical symptoms, PPD test                            PCR-RFLP            No symptoms                                                       Not available                                           Not available        Not available
  2007   Olesen         Guinea-Bissau                   Papel, Manjaco, Mancanha, Balanta, Fulani, Mandinka and others   PB             Pulmonary tuberculosis                                       320/344                      AFB smear and clinical criteria                        TaqMan              Healthy controls                                                  HIV positive in 33% of cases and negative in controls   Gender not matched   Not available
  2007   Babb           South Africa                    South African                                                    HB             Pulmonary tuberculosis                                       249/352                      AFB smear and X-ray                                    PCR-RFLP            No clinical history or symptoms of TB                             Negative                                                Not available        Not available
  2007   Soborg         Tanzania                        Tanzanian                                                        HB             Pulmonary tuberculosis                                       435/416                      Culture                                                PCR-SSP             Culture negative                                                  HIV positive in 44% of cases and 18% of controls        Gender not matched   Not available
  2006   Chen XR        China                           Chinese Tibetans                                                 PB             Pulmonary tuberculosis                                       140/139                      Clinical symptoms, AFB smear and X-ray                 PCR-RFLP            Household contacts                                                Negative                                                Matched              Negative
  2006   Lombard        Venda                           Venda                                                            HB             Pulmonary and meningeal tuberculosis                         66/86                        AFB smear                                              ARMS-PCR            Healthy controls with no history of TB                            Negative                                                Not available        Not available
  2004   Bornman        Gambia, Guinea-Bissau, Guinea   Gambia, Guinea-Bissau, Guinea                                    HB             Pulmonary tuberculosis                                       416/718                      AFB or culture                                         PCR-RFLP            Healthy community control subjects                                Cases (12.5%), controls (6.8%)                          Matched              Not available
  2004   Selvaraj^a^    India                           Indian                                                           HB             Spinal tuberculosis patients                                 64/103                       X-ray and clinical criteria                            PCR-RFLP            77 were contacts and 26 were normal healthy subjects              Not available                                           Matched              Not available
  2004   Selvaraj^b^    India                           Indian                                                           HB             Pulmonary tuberculosis                                       46/64                        AFB smear, culture and radiographic abnormalities      PCR-RFLP            Clinically normal                                                 Negative                                                Matched              Not available
  2004   Roth           Peru                            Amerindian                                                       PB             Pulmonary tuberculosis                                       100/201                      AFB smear                                              PCR-RFLP            Two healthy controls, 1 PPD + and 1 PPD--                         Negative                                                Matched              Not available
  2004   Liu            China                           Chinese Han                                                      PB             Pulmonary tuberculosis                                       120/240                      AFB smear, culture and X-ray                           PCR-RFLP            Normal controls                                                   Negative                                                Not available        Negative
  2004   Liu            China                           Chinese Han                                                      PB             Pulmonary tuberculosis                                       76/171                       Culture and X-ray                                      PCR-RFLP            Normal controls                                                   Not available                                           Matched              Negative
  2003   Selvaraj       India                           Indian                                                           HB             Pulmonary tuberculosis                                       120/80                       Culture                                                PCR-RFLP            Patient contacts                                                  Not available                                           Matched              Not available
  2000   Wilkinson      India                           Gujarati                                                         HB             Pulmonary tuberculosis (27) and military tuberculosis (64)   91/116                       Biopsy or culture Tuberculosis                         PCR-RFLP            Contacts with no TB                                               Negative                                                Gender not matched   Not available

PB -- population-based, HB -- hospital-based, AFB -- acid-fast bacilli, HIV -- human immunodeficiency virus, MDR -- multi-drug resistance for isoniazid and rifampicin, PPD -- purified protein derivative, SNPs -- single nucleotide polymorphism, TB -- tuberculosis, PCR-RFLP -- polymerase chain reaction--restriction fragment length polymorphism.

###### 

Distribution of gene polymorphism of studies included in the meta-analysis

  Year   First author                                  Case   Control                                        
  ------ --------------------------------------------- ------ --------- ---- ------ ----- ----- ----- ------ --------
  2014   Arji                                          151    103       20   0.26   109   82    12    0.26   0.5038
  2014   Mahmoud                                       12     20        8    0.45   10    10    5     0.4    0.404
  2014   Sinaga                                        27     42        7    0.37   30    34    12    0.38   0.6497
  2013   Fang                                          72     96        45   0.44   101   88    22    0.31   0.6642
  2013   Joshi                                         51     46        13   0.33   118   85    22    0.29   0.252
  2012   Rathored                                      319    298       75   0.32   118   80    7     0.23   0.1356
  2011   Kim                                           47     75        38   0.47   46    73    37    0.47   0.4463
  2011   Kang                                          30     58        15   0.43   41    43    21    0.40   0.1240
  2011   Singh                                         55     40        6    0.26   96    110   19    0.33   0.1069
  2011   Sharma                                        77     67        10   0.28   395   197   36    0.21   0.0880
  2011   Ates                                          58     60        10   0.31   35    37    8     0.33   0.6945
  2010   Marashian                                     97     57        10   0.23   15    30    5     0.40   0.0771
  2010   Zhang                                         16     43        51   0.66   26    47    29    0.51   0.4330
  2009   Banoei                                        30     21        9    0.33   29    27    6     0.31   0.9375
  2009   Merza                                         67     46        4    0.23   35    25    0     0.21   0.0415
  2009   Vidyarani                                     23     14        3    0.25   20    29    0     0.30   0.0033
  2009   Selvaraj                                      33     29        3    0.27   33    26    1     0.23   0.1019
  2009   Alagarasu                                     138    66        13   0.21   81    59    4     0.23   0.0766
  2008   Selvaraj                                      31     16        4    0.24   27    33    0     0.28   0.0033
  2008   Liu                                           16     25        19   0.53   11    17    2     0.35   0.1789
  2007   Wilbur                                        35     19        0    0.18   81    42    1     0.18   0.0740
  2007   Olesen                                        198    106       16   0.22   207   118   19    0.23   0.6862
  2007   Babb                                          132    104       13   0.26   203   129   20    0.24   0.9337
  2007   Soborg                                        288    128       19   0.19   267   128   21    0.20   0.2734
  2006   Chen                                          60     56        24   0.37   70    60    9     0.28   0.4144
  2006   Lombard                                       43     21        2    0.19   64    18    2     0.13   0.5917
  2004   Bornman                                       258    138       20   0.21   444   242   32    0.21   0.8932
  2004   Selvaraj^[a](#TF0006){ref-type="table-fn"}^   47     15        2    0.15   55    39    9     0.28   0.5834
  2004   Selvaraj^[b](#TF0006){ref-type="table-fn"}^   28     15        3    0.23   38    23    3     0.23   0.8388
  2004   Roth                                          9      32        59   0.75   14    78    109   0.74   0.9928
  2004   Liu                                           29     63        28   0.50   85    120   35    0.40   0.4821
  2004   Liu W                                         29     34        13   0.39   90    70    11    0.27   0.5930
  2003   Selvaraj                                      78     36        6    0.20   43    29    8     0.28   0.3551
  2000   Wilkinson                                     52     31        8    0.26   74    39    3     0.19   0.4178

HWE -- Hardy-Weinberg equilibrium, MAF -- minor allele frequency

the different articles by the same author in the same year.

Sensitivity analyses and publication bias {#S20009}
-----------------------------------------

In the sensitivity analysis, the influence of each individual data set on the pooled OR was assessed by deleting one single study each time. The results showed that the corresponding pooled ORs were not materially varied, suggesting stability of this meta-analysis (data not shown). Begg\'s funnel plot and Egger\'s test were used to evaluate the publication bias of the selected studies for the meta-analysis ([Figure 2](#F0002){ref-type="fig"}). Begg\'s funnel plot seemed symmetrical in all genetic models. Furthermore, the statistical results from Egger\'s test supported the result of Begg\'s funnel plot indicating that there was no publication bias among all genetic models (*p* \> 0.05) ([Table III](#T0003){ref-type="table"}).

![Funnel plot analysis to detect publication bias in 34 eligible studies. **A** -- Funnel plot analysis of homozygote model (ff vs. FF). Egger\'s test *p* = 0.567, Begg\'s test *p* = 0.423; **B** -- Funnel plot analysis of recessive model (ff vs. Ff + FF). Egger\'s test *p* = 0.419, Begg\'s test *p* = 0.343; the circles represent the weight of individual study. log -- logarithm, SE -- standard error (TIF)](AMS-12-27637-g002){#F0002}

###### 

Statistics to test the publication bias and heterogeneity in the meta-analysis

  Comparisons      Begg\'s regression analysis   Egger\'s regression analysis   Heterogeneity analysis   Model used for the meta-analysis                  
  ---------------- ----------------------------- ------------------------------ ------------------------ ---------------------------------- ------- ------ --------
  f vs. F          0.614                         (--1.133)--0.404               0.341                    88.47                              0.000   62.7   Random
  ff vs. FF        0.441                         (--0.327)--0.574               0.580                    65.90                              0.001   49.9   Random
  Ff vs. FF        0.313                         (--0.949)--0.241               0.234                    66.35                              0.001   50.3   Random
  ff + Ff vs. FF   0.459                         (--0.918)--0.409               0.440                    79.44                              0.000   58.5   Random
  ff vs. Ff + FF   0.495                         (--0.327)--0.640               0.514                    57.01                              0.006   42.1   Random

Meta-analysis results {#S20010}
---------------------

We pooled all 34 studies together for the assessment of the relationship between the VDR FokI polymorphism and the risk of TB. The pooled ORs from overall studies indicated a significantly increased risk of TB in the homozygote model (ff vs. FF: OR = 1.37, 95% CI: 1.17--1.60; *P*~heterogeneity~ = 0.001, [Figure 3](#F0003){ref-type="fig"}) and recessive model (ff vs. Ff + FF: OR = 1.32, 95% CI: 1.14--1.52; *P*~heterogeneity~ = 0.006, [Figure 4](#F0004){ref-type="fig"}). However, no significant association was found in the allele model (f vs. F: OR = 1.09, 95% CI: 0.97--1.21; *P*~heterogeneity~ = 0.000, [Figure 5](#F0005){ref-type="fig"}) and in the dominant model (ff + Ff vs. FF: OR = 1.08, 95% CI: 0.99--1.17; *P*~heterogeneity~ = 0.000, [Figure 6](#F0006){ref-type="fig"}). The heterozygote model (Ff vs. FF: OR = 1.03, 95% CI: 0.95--1.13; *P*~heterogeneity~ = 0.001, [Figure 7](#F0007){ref-type="fig"}) failed to show any association with the risk of TB. The strength of the association between VDR FokI gene polymorphism and TB risk is shown in [Table IV](#T0004){ref-type="table"}.

![Forest plot of homozygote model for overall comparison (ff vs. FF) (TIF)](AMS-12-27637-g003){#F0003}

![Forest plot of recessive model for overall comparison (ff vs. Ff + FF) (TIF)](AMS-12-27637-g004){#F0004}

![Forest plot of allele model for overall comparison (f vs. F) (TIF)](AMS-12-27637-g005){#F0005}

![Forest plot of dominant model for overall comparison (ff + Ff vs. FF) (TIF)](AMS-12-27637-g006){#F0006}

![Forest plot of heterozygote model for overall comparison (Ff vs. FF) (TIF)](AMS-12-27637-g007){#F0007}

###### 

Meta-analysis results

  Variable                                     f vs. F   ff vs. FF                                             ff vs. Ff + FF   ff vs. FF                                             ff + Ff vs. FF                                                                                                                                                   
  -------------------------------------------- --------- ----------------------------------------------------- ---------------- ----------------------------------------------------- ---------------- ----------------------------------------------------- ------- ------------------- ------- ----------------------------------------------------- -------
  Total                                        34        1.09 (0.97--1.21)                                     0.000            1.37 (1.17--1.60)[\*](#TF0001){ref-type="table-fn"}   0.001            1.32 (1.14--1.52)[\*](#TF0001){ref-type="table-fn"}   0.006   1.03 (0.95--1.13)   0.001   1.08 (0.99--1.17)                                     0.000
  Ethnicities:                                                                                                                                                                                                                                                                                                                                         
   ES Asians                                   9         1.42 (1.20--1.69)[\*](#TF0001){ref-type="table-fn"}   0.055            1.98 (1.53--2.56)[\*](#TF0001){ref-type="table-fn"}   0.012            1.64 (1.31--2.06)[\*](#TF0001){ref-type="table-fn"}   0.003   1.37 (1.13--1.65)   0.853   1.52 (1.27--1.82)[\*](#TF0001){ref-type="table-fn"}   0.695
   SW Asians                                   15        0.92 (0.75--1.13)                                     0.000            1.28 (0.95--1.74)                                     0.007            1.33 (1.00--1.78)[\*](#TF0001){ref-type="table-fn"}   0.045   0.91 (0.79--1.05)   0.000   0.97 (0.85--1.11)                                     0.000
   Africans                                    7         1.01 (0.91--1.12)                                     0.731            1.01 (0.75--1.35)                                     0.985            0.10 (0.75--1.32)                                     0.990   1.02 (0.89--1.17)   0.533   1.01 (0.88--1.15)                                     0.525
   Americans                                   2         1.05 (0.76--1.45)                                     0.821            0.84 (0.35--1.98)                                     0.955            1.20 (0.74--1.94)                                     0.775   0.88 (0.51--1.53)   0.399   0.92 (0.54--1.56)                                     0.592
   Europeans                                   1         0.92 (0.60--1.40)                                     --.              0.75 (0.27--2.09)                                     --               0.76 (0.29--2.02)                                     --      0.98 (0.54--1.76)   --      0.94 (0.54--1.65)                                     --
  Sample size:                                                                                                                                                                                                                                                                                                                                         
   Large[a](#TF0002){ref-type="table-fn"}      4         1.09 (0.97--1.21)                                     0.003            1.34 (0.96--1.88)                                     0.022            1.26 (0.90--1.76)                                     0.048   1.15 (0.99--1.34)   0.023   1.18 (1.02--1.36)[\*](#TF0001){ref-type="table-fn"}   0.000
   Small[b](#TF0003){ref-type="table-fn"}      30        1.06 (0.94--1.20)                                     0.000            1.38 (1.15--1.64)[\*](#TF0001){ref-type="table-fn"}   0.002            1.33 (1.14--1.56)[\*](#TF0001){ref-type="table-fn"}   0.012   0.98 (0.89--1.09)   0.003   1.04 (0.94--1.14)                                     0.006
  Genotyping method:                                                                                                                                                                                                                                                                                                                                   
   PCR-RFLP                                    29        1.08 (0.95--1.22)                                     0.000            1.47 (1.23--1.75)[\*](#TF0001){ref-type="table-fn"}   0.001            1.39 (1.19--1.63)[\*](#TF0001){ref-type="table-fn"}   0.010   1.05 (0.95--1.15)   0.000   1.10 (1.00--1.20)[\*](#TF0001){ref-type="table-fn"}   0.000
   Other methods                               5         1.07 (0.86--1.33)                                     0.114            1.02 (0.71--1.45)                                     0.235            1.03 (0.74--1.44)                                     0.196   0.99 (0.81--1.19)   0.642   0.99 (0.83--1.19)                                     0.447
  Source of controls:                                                                                                                                                                                                                                                                                                                                  
   Contacts[c](#TF0004){ref-type="table-fn"}   10        0.97 (0.75--1.26)                                     0.000            1.24 (0.91--1.68)                                     0.002            1.33 (1.03--1.71)[\*](#TF0001){ref-type="table-fn"}   0.022   0.93 (0.78--1.11)   0.012   0.99 (0.83--1.17)                                     0.001
   Healthy[d](#TF0005){ref-type="table-fn"}    24        1.13 (1.01--1.27)[\*](#TF0001){ref-type="table-fn"}   0.001            1.42 (1.18--1.70)[\*](#TF0001){ref-type="table-fn"}   0.019            1.31 (1.10--1.56)[\*](#TF0001){ref-type="table-fn"}   0.028   1.07 (0.97--1.17)   0.006   1.11 (1.01--1.21)[\*](#TF0001){ref-type="table-fn"}   0.001

N -- number of studies included, OR -- odds ratio, P~h~ -- p-value for heterogeneity

OR with statistical significance

studies with more than 500 participants

studies with less than 5000 participants

studies with controls from patient contacts

studies with controls from healthy persons

To account for the sources of heterogeneity, we performed meta-regression by publication years, ethnicity, sample size, genotyping methods, as well as source of controls and type of TB. However, no significant source was found to substantially contribute to heterogeneity ([Table V](#T0005){ref-type="table"}).

###### 

Meta-regression analysis results

  Variable               f vs. F   ff vs. FF          ff vs. Ff + FF   Ff vs. FF          ff + Ff vs. FF                                                                          
  ---------------------- --------- ------------------ ---------------- ------------------ ---------------- ------------------ ------ ------------------ ------ ------------------ ------
  Publication years      34        (--52.14)--23.05   0.44             (--92.13)--90.56   0.99             (--76.13)--88.01   0.88   (--65.78)--36.31   0.56   (--61.78)--35.21   0.58
  Ethnicities            34        (--0.48)--0.40     0.86             (--1.17)--0.96     0.85             (--1.13)--0.90     0.82   (--0.62)--0.60     0.98   (--0.614)--0.56    0.92
  Sample size            34        (--0.06)--0.19     1.08             (--0.24)--0.46     0.52             (--0.25)--0.45     0.56   (--0.10)--0.22     0.44   (--0.08)--0.220    0.35
  Genotyping method      34        (--0.15)--0.15     0.96             (--0.38)--0.37     0.98             (--0.33)--0.36     0.94   (--0.21)--0.19     0.95   (--0.19)--0.19     0.97
  Source of controls     34        (--0.11)--0.15     0.76             (--0.28)--0.37     0.78             (--0.14)--0.39     0.36   (--0.22)--0.15     0.74   (--0.18)--0.17     0.95
  Type of tuberculosis   34        (--0.21)--0.99     0.97             (--0.45)--0.51     0.90             (--0.40)--0.46     0.89   (--0.32)--0.25     0.79   (--0.29)--0.25     0.87

To further investigate the heterogeneity, we performed subgroup analyses ([Table IV](#T0004){ref-type="table"}). To evaluate the possible effect of the geographical differences on the variability of overall estimates, we classified the studies conducted in Asia into two groups: East and Southeast Asia (China, Indonesian and South Korean) and South and West Asia (India and Iran). As a result, the enrolled studies were divided into five subgroups including Africans, East and Southeast Asians, South and West Asians, Americans and Europeans. As for ethnicities, an increased TB risk was found in the East and Southeast Asia population in five comparison models: allele model (f vs. F: OR = 1.42, 95% CI: 1.20--1.69; *P*~heterogeneity~ = 0.055), homozygote model (ff vs. FF: OR = 1.98, 95% CI:1.53--2.56; *P*~heterogeneity~ = 0.012), recessive model (ff vs. Ff + FF: OR = 1.64, 95% CI: 1.31--2.06; *P*~heterogeneity~ = 0.003), heterozygote model (Ff vs. FF: OR = 1.37, 95% CI: 1.13--1.65; *P*~heterogeneity~ = 0.853) and dominant model (ff + Ff vs. FF: OR = 1.52, 95% CI: 1.27--1.82; *P*~heterogeneity~ = 0.695). In South and West Asians, however, no significant association was found in the heterozygote model (ff vs. Ff + FF: OR = 1.33, 95% CI: 1.00--1.78; *P*~heterogeneity~= 0.045).

Further subgroup analyses were stratified by the source of the controls. Studies were divided into healthy persons-based and patient contacts-based studies, and importantly the association in healthy persons-based studies was reinforced in the allele model (f vs. F: OR = 1.13, 95% CI: 1.01--1.27; *P*~heterogeneity~ = 0.001), the homozygote model (ff vs. FF: OR = 1.42, 95% CI: 1.18--1.70; *P*~heterogeneity~ = 0.019) and the recessive model (ff vs. Ff + FF: OR = 1.31, 95% CI: 1.10--1.56; *P*~heterogeneity~ = 0.028), which conferred a significantly increased risk of TB, whereas this risk was reversed in patient contacts-based studies with no significance in each model ([Table IV](#T0004){ref-type="table"}).

In addition, when categorized by the sample size with a cutoff of 500 individuals, 30 out of 34 studies had sample sizes less than 500 and conferred an increased risk of TB for two comparison models: the homozygote model (ff vs. FF: OR = 1.38, 95% CI: 1.15--1.64; *P*~heterogeneity~ = 0.002) and the recessive model (ff vs. Ff + FF: OR = 1.33, 95% CI: 1.14--1.56; *P*~heterogeneity~ = 0.012). For the subgroup analysis by the genotyping methods, the homozygote model (ff vs. FF: OR = 1.47, 95% CI: 1.23--1.75; *P*~heterogeneity~ = 0.001), recessive genetic model (ff vs. Ff + FF: OR = 1.39, 95% CI: 1.19--1.63; *P*~heterogeneity~ = 0.010) and dominant model (ff + Ff vs. FF: OR = 1.10, 95% CI: 1.00--1.20; *P*~heterogeneity~ = 0.000) remained statistically significant in PCR-RFLP studies ([Table IV](#T0004){ref-type="table"}).

Discussion {#S0011}
==========

Tuberculosis is one of the leading causes of morbidity and mortality, and the VDR gene might be important in modulating host susceptibility to TB because of the potential roles of VDR in the immune response to TB. However, many studies generated conflicting association data concerning the association between VDR FokI gene polymorphism and the risk of TB.

Our present meta-analysis, based on 34 eligible studies until January 2015, provides evidence to propose a consistent effect of VDR FokI polymorphism. We found that the f allele was associated with a significantly increased risk of TB in the homozygote model (ff vs. FF) and the recessive model (ff vs. Ff + FF), especially in the East and Southeast Asian population. However, an insignificant association was found in South and West Asians, Africans, Americans and Europeans for all comparison models. To a certain extent, this finding could reflect the existence of racial differences, suggesting that this polymorphism might have a multifunctional role in the pathogenesis of TB or interact with other genetic and environmental factors. Previous studies including the WHO TB report suggested that the yellow race was more susceptible to TB than the black and white race \[[@CIT0001]\]. Additionally, it was reported that the f allele frequency was higher in Asians than Africans \[[@CIT0017]\]. Thus, the finding of this meta-analysis might be attributed to the racial differences.

There are some limitations to this systematic review. First, some individual information such as age, sex, HIV status and environmental factors could not be obtained, which makes the detailed sub-grouping analyses and interpretation of the results difficult. Second, considering that diabetes, hypertension and any other medical problem may affect vitamin D level, the confounding effect should be taken into account. VDR FokI polymorphisms have been suggested to be related to diabetes in Asians \[[@CIT0046]\]. Diabetes status in the study population may therefore influence the association observed for VDR polymorphisms and TB incidence. Therefore, the stratification of diabetes status would further reveal the relationship between VDR gene SNPs and TB. However, diabetes status was not reported in two-thirds of the enrolled studies. Therefore, it was not possible to apply stratification according to diabetes status. Third, the small sample sizes in some subgroup analyses may not comprehensively represent the population. More studies are needed to confirm the association of FokI polymorphisms and TB risk, especially in different ethnic populations. Fourth, the different experimental designs and diagnostic standards make the analyses prone to bias. Fifth, included studies were restricted to those published in English or Chinese in our study, which might introduce potential bias into data analysis as well. Sixth, based on the data provided by the articles and our own calculations, significant deviations from HWE (*p* \< 0.05) in controls were observed for three studies based on Asians \[[@CIT0031], [@CIT0032], [@CIT0035]\]. Thus, their results should be interpreted with more caution. We therefore repeated the meta-analyses after exclusion of these studies. However, this exclusion did not materially affect the results ([Table VI](#T0006){ref-type="table"}). Although genome-wide association studies (GWAS) are important for the discovery of genetic variations, we did not identify any published GWAS on this subject. In conclusion, the results from this meta-analysis demonstrate that VDR FokI polymorphism is associated with increased TB risk, especially in East and Southeast Asians, which supports the hypothesis that VDR might play an important role in the host defense against TB. However, due to the moderate strength of the associations, their values to be used for risk prediction should be considered cautiously, and future large scale case-control studies are required to validate these findings.

###### 

Sensitivity analyses of study with controls not in HWE excluded

  Study with controls not in HWE excluded   Summarized odds ratio (95% CI)   No. of included studies   *I*^2^ (%)   *P*-value
  ----------------------------------------- -------------------------------- ------------------------- ------------ -----------
  f vs. F                                   1.097 (0.978--1.229)             31                        65.3         0.113
  ff vs. FF                                 1.323 (1.037--1.689)             31                        52.3         0.025
  ff vs. Ff + FF                            1.320 (1.083--1.608)             31                        39.7         0.006
  Ff vs. FF                                 1.042 (0.917--1.185)             31                        47.4         0.526
  ff + Ff vs. FF                            1.085 (0.945--1.246)             31                        58.8         0.246

CI -- confidence interval.
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